Inozyme Pharma Inc (INZY)
3.42
-0.13
(-3.66%)
USD |
NASDAQ |
Nov 14, 16:00
3.50
+0.08
(+2.34%)
After-Hours: 20:00
Inozyme Pharma Total Assets (Quarterly): 143.36M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 143.36M |
| June 30, 2024 | 155.71M |
| March 31, 2024 | 176.94M |
| December 31, 2023 | 200.85M |
| September 30, 2023 | 205.70M |
| June 30, 2023 | 150.93M |
| March 31, 2023 | 141.80M |
| December 31, 2022 | 139.20M |
| September 30, 2022 | 154.02M |
| June 30, 2022 | 161.99M |
| Date | Value |
|---|---|
| March 31, 2022 | 108.93M |
| December 31, 2021 | 123.54M |
| September 30, 2021 | 137.75M |
| June 30, 2021 | 148.26M |
| March 31, 2021 | 158.92M |
| December 31, 2020 | 169.36M |
| September 30, 2020 | 178.99M |
| June 30, 2020 | 68.51M |
| March 31, 2020 | 75.74M |
| December 31, 2019 | 47.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
47.94M
Minimum
Dec 2019
205.70M
Maximum
Sep 2023
142.42M
Average
149.59M
Median
Total Assets (Quarterly) Benchmarks
| Tango Therapeutics Inc | 352.42M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 60.57M |
| Shareholders Equity (Quarterly) | 82.79M |